The Department of Health and Mental Hygeine published the award notice Sept. 21, but PharmAthene has not received an executed agreement for the contract yet, officials said.
Last year the firm won a multiyear deal worth up to $213 million to develop its treatment for nerve agents for the Department of Defense. The contract provides the Department of Defense with an option to procure an initial...
| This story has expired! You can purchase the full text in our news archives. |

If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.
In order to post or vote on a comment, you must be signed in with a hometownannapolis account.
Take a look at a summary of Commenting Guidelines.
If you encounter other problems, please email nlundskow@capitalgazette.com and include your name, username, and any errors or messages that are displayed. The more information you can provide, the better able we will be to assist you.